Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

WRK W006 - Adverse Drug Reactions: The Evidence and the Controversies

Tuition fee and ticket required for admission


Date: Friday, March 21

CME Credits: 2.00

Location: Mile High Ballroom 2A

Time: 3:30 PM - 5:30 PM

Director: David R. Adams, MD, PharmD, FAAD - Handout

  • Joel M. Gelfand, MD, MSCE, FAAD
  • Neil H. Shear, MD, FAAD
  • Stephen E. Wolverton, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Recognize many and some new adverse drug reactions/interactions in dermatology.
  • Discuss the current diagnostic/treatment approaches to adverse drug reactions/interactions in dermatology.
  • Define medicolegal risks for adverse drug reactions.

Over 100 adverse drug reactions (ADRs) affecting the skin, hair, or nails are noted in the literature. Drug interactions (DIs) are also a persistent potential risk with multi-drug regimens. We will discuss some of these reactions, some well known and others that occur less frequently or are newly reported. Most ADRs and DIs are self-limited and only require discontinuation of the suspected offending medication, while others are life-threatening and require intervention. Diagnostic approaches and difficulties will be discussed, as well as treatment strategies where indicated. Although in-depth basic science is still lacking in this field, we will discuss mechanisms where appropriate. Medicolegal issues will also be discussed.


Friday, March 21
3:30 PMIntroduction: Adverse Drug Reactions / Dr. Adams
3:45 PMCurrent Controversies in Safety of Dermatological Therapeutics / Dr. Gelfand
4:15 PMDrug Interactions to Worry About / Dr. Shear
4:45 PMDrug Safety and Medicolegal Risk / Dr. Wolverton